Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleAtogepant Safe, Effective in Treatment-Resistant Episodic Migraine: Daily Dose.AuthorsJennings, SydneySubjectsCALCITONIN gene-related peptide; MIGRAINE prevention; MEDICATION safety; DRUG efficacy; DRUG dosagePublicationPatient Care (Online), 2024, p1ISSN1939-1897Publication typeArticle